Skip to main content
Premium Trial:

Request an Annual Quote

Scott Kahn

Optra Health has appointed Scott Kahn as chief strategy advisor. In this role, he will oversee strategic direction for the company's knowledge automation and analytics platform — iPhronesis — for genomics-related research, digital drug development, real world evidence, and personalized healthcare. Kahn comes to Optra Health from Illumina, where he served as chief information officer for nine years.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.